Navigation path

Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information

(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid

EU orphan designation number: EU/3/05/277
Active ingredient: (3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid
Indication: Treatment of cystic fibrosis
Sponsor: PTC Therapeutics International Limited
77 Sir John Rogerson’s Quay, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Orphan designation EMEA/OD/107/04 (2005)1650 of 27/05/2005
22/05/2007 Transfer of orphan designation EMEA/OD/107/04/T/01 (2007)2145 of 14/05/2007
7/05/2013 Transfer of orphan designation EMEA/OD/107/04/T/02 (2013)2734 of 3/05/2013
5/08/2014 Change of name and/or address of sponsor
10/06/2015 Transfer of orphan designation EMA/OD/107/04/T/03 (2015)3924 of 5/06/2015
24/04/2017 Removal of orphan designation from Community Register